Cargando…

Implementation of universal testing for severe acute respiratory syndrome coronavirus 2 in pregnant women with intended admission for delivery

Detalles Bibliográficos
Autores principales:	Berkowitz, Kathleen M., Goje, Oluwatosin, Eaton, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351653/ https://www.ncbi.nlm.nih.gov/pubmed/32659226 http://dx.doi.org/10.1016/j.ajog.2020.07.011

Ejemplares similares

Universal severe acute respiratory syndrome coronavirus 2 testing of pregnant women admitted for delivery in 2 Italian regions
por: Gagliardi, Luigi, et al.
Publicado: (2020)

Optimizing mother–baby wellness during the 2019 coronavirus disease pandemic: A case for telemedicine
por: Markwei, Metabel, et al.
Publicado: (2021)

Delivery for respiratory compromise among pregnant women with coronavirus disease 2019
por: McLaren, Rodney A., et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 antibodies in pregnant women admitted to labor and delivery units
por: Haizler-Cohen, Lylach, et al.
Publicado: (2021)

Pregnant women's perspectives on severe acute respiratory syndrome coronavirus 2 vaccine
por: Carbone, Luigi, et al.
Publicado: (2021)

Risk factors for severe acute respiratory syndrome coronavirus 2 infection in pregnant women
por: Sakowicz, Allie, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 serology levels in pregnant women and their neonates
por: Kubiak, Jeffrey M., et al.
Publicado: (2021)

Intensive care unit admissions for pregnant and nonpregnant women with coronavirus disease 2019
por: Westgren, Magnus, et al.
Publicado: (2020)

Intensive care unit admissions for pregnant and nonpregnant women with coronavirus disease 2019
por: Blitz, Matthew J., et al.
Publicado: (2020)

Rapid antigen detection testing for universal screening for severe acute respiratory syndrome coronavirus 2 in women admitted for delivery
por: Rottenstreich, Amihai, et al.
Publicado: (2021)

Universal testing of patients and their support persons for severe acute respiratory syndrome coronavirus 2 when presenting for admission to labor and delivery at Mount Sinai Health System
por: Buckley, Ayisha, et al.
Publicado: (2020)

Pregnant vs nonpregnant severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 hospital admissions: the first 4 weeks in New York
por: Tekbali, Asma, et al.
Publicado: (2020)

Practical considerations for pregnant women with diabetes and severe acute respiratory syndrome coronavirus 2 infection
por: Boyles, Glenn P., et al.
Publicado: (2020)

Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France
por: Vivanti, Alexandre J., et al.
Publicado: (2020)

Risk for postpartum depressive symptoms among pregnant women in a tertiary care setting with and without a positive COVID-19 test
por: Taljan, Katherine E., et al.
Publicado: (2022)

“Characterization of Nanoparticles Intended for Drug Delivery”
por: Gabor, Franz
Publicado: (2011)

Impact of the COVID-19 Pandemic and Obstetrician and Gynecologist Workforce Distribution on Vaccine Deployment and Predicting Women’s Healthcare Shortages
por: Shastri, Toral, et al.
Publicado: (2021)

Risk for Postpartum Depression Among Women Positive for COVID-19 During Pregnancy
por: Taljan, Katherine, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg
por: Khalil, Asma, et al.
Publicado: (2020)

Mycoplasma genitalium: An Emerging Sexually Transmitted Infection
por: Munoz, Jessian L., et al.
Publicado: (2016)

Repeat positive severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) testing ≥90 days apart in pregnant women
por: Dubelbeiss, Emily, et al.
Publicado: (2021)

Partner testing of severe acute respiratory syndrome coronavirus 2–positive women presenting for delivery
por: Sakowicz, Allie, et al.
Publicado: (2021)

Low Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Pregnant and Postpartum Patients With Universal Screening in Seattle, Washington
por: LaCourse, Sylvia M, et al.
Publicado: (2020)

Screening for coronavirus disease 2019 in pregnant women admitted for delivery: an observational study
por: Cavalcante, Ana Nery Melo, et al.
Publicado: (2023)

Intended versus actual delivery location and factors associated with change in delivery location among pregnant women in Southern Province, Zambia: a prespecified secondary observational analysis of the ZamCAT
por: Solomon, Hiwote, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 detected in placentas of 2 coronavirus disease 2019–positive asymptomatic pregnant women—case report
por: Sanchez, Jaime, et al.
Publicado: (2020)

Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan
por: Uchida, Sho, et al.
Publicado: (2021)

Severe maternal morbidity in pregnant patients with severe acute respiratory syndrome coronavirus 2 infection
por: Gulersen, Moti, et al.
Publicado: (2022)

Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State
por: Lokken, Erica M., et al.
Publicado: (2020)

Clinical Characteristics and Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnant Women and Their Neonates in Korea
por: Lee, Jiyoung, et al.
Publicado: (2023)

Appointment in Michigan University and Admission of Women
Publicado: (1871)

Dataset of certified food dye levels in over the counter medicines and vitamins intended for consumption by children and pregnant women
por: Lehmkuhler, Arlie L., et al.
Publicado: (2020)

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019
por: Burwick, Richard M, et al.
Publicado: (2020)

Framework for identification and measurement of spillover effects in policy implementation: intended non-intended targeted non-targeted spillovers (INTENTS)
por: Francetic, Igor, et al.
Publicado: (2022)

(31) Characterizing Stress and Sources of Information Related to Vaccination Against SARS-CoV-2 During Pregnancy
por: De Souza, Larissa, et al.
Publicado: (2022)

Term breech presentation—Intended cesarean section versus intended vaginal delivery—A systematic review and meta‐analysis
por: Wängberg Nordborg, Julia, et al.
Publicado: (2022)

Specialized prenatal care delivery for coronavirus disease 2019–exposed or –infected pregnant women
por: Dotters-Katz, Sarah K., et al.
Publicado: (2021)

Timing of delivery with coronavirus disease 2019 pneumonia requiring intensive care unit admission
por: Rose, Carl H., et al.
Publicado: (2021)

Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans
por: DiNapoli, Joshua M., et al.
Publicado: (2009)

Therapeutic options in the treatment of severe acute respiratory syndrome coronavirus 2 in pregnant patient
por: Lat, Tasnim I., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2pqp1rtvvkpmnif12tu1f91vmt